Find Naringenin manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 480-41-1, Salipurpol, Salipurol, (s)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one, (s)-naringenin, Pelargidanon
Molecular Formula
C15H12O5
Molecular Weight
272.25  g/mol
InChI Key
FTVWIRXFELQLPI-ZDUSSCGKSA-N
FDA UNII
HN5425SBF2

Naringenin
naringenin is a natural product found in Elaeodendron croceum, Garcinia multiflora, and other organisms with data available.
1 2D Structure

Naringenin

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2S)-5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one
2.1.2 InChI
InChI=1S/C15H12O5/c16-9-3-1-8(2-4-9)13-7-12(19)15-11(18)5-10(17)6-14(15)20-13/h1-6,13,16-18H,7H2/t13-/m0/s1
2.1.3 InChI Key
FTVWIRXFELQLPI-ZDUSSCGKSA-N
2.1.4 Canonical SMILES
C1C(OC2=CC(=CC(=C2C1=O)O)O)C3=CC=C(C=C3)O
2.1.5 Isomeric SMILES
C1[C@H](OC2=CC(=CC(=C2C1=O)O)O)C3=CC=C(C=C3)O
2.2 Other Identifiers
2.2.1 UNII
HN5425SBF2
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 4',5,7-trihydroxyflavanone

2. Be 14348a

3. Be-14348a

4. Naringenin-7-sulfate

2.3.2 Depositor-Supplied Synonyms

1. 480-41-1

2. Salipurpol

3. Salipurol

4. (s)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one

5. (s)-naringenin

6. Pelargidanon

7. (2s)-naringenin

8. Naringetol

9. Naringenine

10. Asahina

11. Nsc 11855

12. Ccris 5839

13. (-)-naringenin

14. Yso1

15. Nsc 34875

16. (-)-(2s)-naringenin

17. Chembl9352

18. (s)-2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4h-1-benzopyran-4-one

19. Ai3-23355

20. Hn5425sbf2

21. Chebi:17846

22. Flavanone, 4',5,7-trihydroxy-

23. 2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4h-1-benzopyran-4-one

24. 4h-1-benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-, (2s)-

25. Narigenin

26. Nsc-11855

27. (2s)-5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-4h-chromen-4-one

28. 5,7,4'-trihydroxyflavanone

29. (r,s)-naringenin

30. Sr-01000721771

31. (2s)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one

32. Unii-hn5425sbf2

33. 2uxu

34. 4deu

35. S-dihydrogenistein

36. Einecs 207-550-2

37. Pelargidanon 1602

38. Spectrum_000247

39. 4eh3

40. Naringenin [mi]

41. Spectrum2_000325

42. Spectrum3_000567

43. Spectrum4_000124

44. Spectrum5_001423

45. Naringenin [inci]

46. 4',5,7-trioh-flavone

47. 4',5,7-trihydroxyflavanon

48. Naringenin, (-)-

49. Schembl20570

50. Bspbio_001954

51. Kbiogr_000508

52. Kbioss_000727

53. Mls000574861

54. Bidd:er0116

55. Divk1c_000118

56. Spectrum1500746

57. Spbio_000329

58. 4',5, 7-trihydroxyflavanone

59. 5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-4h-chromen-4-one

60. Dtxsid1022392

61. Bdbm23419

62. Hms500f20

63. Kbio1_000118

64. Kbio2_000727

65. Kbio2_003295

66. Kbio2_005863

67. Kbio3_001454

68. 4h-1-benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-, (s)-

69. Ninds_000118

70. (2s)-5,7,4'-trihydroxyflavone

71. Aids001417

72. Hms2202m06

73. Zinc156701

74. (2s)-4',5,7-trihydroxyflavanone

75. Hy-n0100

76. Tnp00287

77. (2s)-5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one

78. (s)-2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4-benzopyrone

79. Ccg-38601

80. Lmpk12140001

81. Phytochemistry 8: 127 (1969)

82. S2394

83. (2s)-5,7-dihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-one

84. Akos016843490

85. Cs-6421

86. Db03467

87. Fs-4072

88. Sdccgmls-0066570.p001

89. (2s)-4',5,7-trihydroxyflavan-4-one

90. Idi1_000118

91. Ncgc00016457-01

92. Ncgc00016457-02

93. Ncgc00016457-03

94. Ncgc00017346-01

95. Ncgc00163598-01

96. Ac-33954

97. Cas-480-41-1

98. Flavanone, 4',5,7-trihydroxy- (8ci)

99. Smr000156272

100. Ft-0617134

101. Sw219329-1

102. C00509

103. A827427

104. Q418374

105. Q-100666

106. Sr-01000721771-3

107. Sr-01000721771-4

108. 5,7-dihydroxy-2-(4-hydroxyphenyl)-4h-chroman-4-one

109. Brd-k08832567-001-02-4

110. Brd-k08832567-001-06-5

111. (-)-(2s)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one

112. (s)-2,3-dihydo-5,7-dihydroxy-2-(4-hydroxyphenyl)-4h-1-benzopyran-4-one

113. 2,3-dihydro-5,6-dihydroxy-2-(4-hydroxyphenyl)-4h-1-benzopyran-4-one

114. 4h-1-benzopyran-4-one,2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-, (2s)-

115. 13308-00-4

2.4 Create Date
2004-09-16
3 Chemical and Physical Properties
Molecular Weight 272.25 g/mol
Molecular Formula C15H12O5
XLogP32.4
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count5
Rotatable Bond Count1
Exact Mass272.06847348 g/mol
Monoisotopic Mass272.06847348 g/mol
Topological Polar Surface Area87 Ų
Heavy Atom Count20
Formal Charge0
Complexity363
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Estrogen Antagonists

Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds. (See all compounds classified as Estrogen Antagonists.)


Anti-Ulcer Agents

Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)


Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty